Global Top 4 Companies Accounted for 63% of total Angiogenesis Assay market (QYResearch, 2021) | |
In vitro assays of angiogenesis typically study the behavior of endothelial cells within a controlled environment. Fundamentally, these in vitro studies are based on purified endothelial cell cultures or carefully controlled co-culture with another cell type (i.e., fibroblasts, immune cells, pericytes, tumor cells). Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal. The global key manufacturers of Angiogenesis Assay include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. In 2021, the global top four players had a share approximately 63.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target Prov.: All Provinces Target City : All Cities Last Update : May 13, 2024 11:17 PM Number of Views: 58 | Item Owner : Elton Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |